NUTX · XBRL financial data
Nutex Health financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (NUTX's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1,586 | 18,794 | 219,294 | 247,646 | 479,949 | 875,257 |
| Cost of revenue | 910 | 14,647 | — | — | — | — |
| Gross profit | 676 | 4,147 | 13,452 | 34,774 | 196,261 | 444,281 |
| Research and development | 557 | 286 | — | — | — | — |
| General and administrative | 3,251 | 12,177 | 18,031 | 33,230 | 41,924 | 51,653 |
| Total operating expenses | 5,864 | 13,165 | 420,052 | 66,548 | 65,563 | 168,656 |
| Operating income (loss) | (5,188) | (9,018) | (406,599) | (31,774) | 130,698 | 275,625 |
| Interest income | 1 | 1 | — | — | — | — |
| Interest expense | 335 | 6,196 | 12,490 | 16,318 | 19,932 | 22,226 |
| Other income (expense) | (502) | (5,635) | (559) | (399) | 669 | (8,618) |
| Income tax expense (benefit) | 0 | (985) | 13,091 | (5,067) | 15,020 | 64,424 |
| Net income (loss) | (5,650) | (13,669) | (424,780) | (45,787) | 52,096 | 70,789 |
| Earnings per share, basic‡ USD per share | 26.87 | 32.84 | (100.00) | (10.45) | 10.23 | 11.13 |
| Earnings per share, diluted‡ USD per share | 26.87 | 32.84 | (100.00) | (10.45) | 9.69 | 10.48 |
| Weighted average shares, basic‡ thousands of shares | 3,972 | 3,972 | 4,254 | 4,430 | 5,091 | 6,361 |
| Weighted average shares, diluted thousands of shares | — | — | 4,233 | 4,408 | 5,492 | 6,756 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (April 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-10 stock split (July 2024); filings made before it reported them unadjusted.
Balance sheet
CSVFiscal years (NUTX's year ends in late December)
- ‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (April 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-10 stock split (July 2024); filings made before it reported them unadjusted.
Cash flows
CSVFiscal years (NUTX's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (5,650) | (13,669) | (424,780) | (45,787) | 52,096 | 70,789 |
| Stock-based compensation | 2,572 | 4,027 | 190 | — | — | — |
| Depreciation and amortization | 5,898 | 5 | 13,131 | 17,592 | 18,972 | 20,530 |
| Net cash from operating activities | (1,475) | (6,704) | 50,607 | 1,256 | 23,154 | 248,125 |
| Purchases of property and equipment | 0 | 36,927 | 14,632 | 9,497 | 2,304 | 2,526 |
| Net cash from investing activities | (61) | 7,952 | (4,337) | (11,240) | (5,606) | (5,242) |
| Proceeds from issuing common stock | — | — | 0 | 0 | 9,203 | 0 |
| Proceeds from issuing equity | 120 | 14,323 | — | — | — | — |
| Share repurchases | — | — | — | 0 | 0 | 5,000 |
| Net cash from financing activities | 497 | 14,039 | (48,133) | (2,270) | 1,091 | (97,949) |
Compare with peers
SIC 7389 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 7389 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Nutex Health | 205,208 | 210,752 | 34,200* | 6.8M | — | 10-QJun 30, 2026 |
| Andersen Group | 175,631 | 217,658 | 69,682* | not reported | — | 10-QJun 30, 2026 |
| Claritev | 14,373 | 257,478 | 92,671* | 16.9M | — | 10-QJun 30, 2026 |
| Cass Information Systems | 228,473 | 49,943 | 16,937* | 12.8M | — | 10-QJun 30, 2026 |
| TIC Solutions | 362,420 | 584,347 | (9,767)* | 218.2M | 37.1 quarters | 10-QJun 30, 2026 |
| CONDUENT | 228,000 | 531,000 | 7,000* | 155.5M | — | 10-QJun 30, 2026 |
| Liquidity Services | 219,751 | 129,578 | 31,173* | 31.3M | — | 10-QJun 30, 2026 |
| MediaAlpha | 18,677 | 375,946 | 21,604* | not reported | — | 10-QSep 30, 2026 |
| Quinstreet | 128,315 | 373,877* | 53,147* | 57.1M | — | 10-KJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
